Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lupus
lupus
Kezar stalls solid tumor trial to focus on autoimmune disease candidate
Pharmaceutical Technology
Wed, 08/14/24 - 11:05 am
Kezar Life Sciences
zetomipzomib
clinical trials
lupus
autoimmune hepatitis
solid tumors
Viatris splashes out $350m on pair of Idorsia therapies
Pharmaphorum
Wed, 02/28/24 - 10:45 am
Viatris
Idorsia
lupus
myocardial infarction
selatogrel
cenerimod
Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Roivant ends longshot lupus program after phase 2 fail
Fierce Biotech
Tue, 11/28/23 - 10:32 am
Roivant
lupus
clinical trials
brepocitnib
AbbVie and Lupus Therapeutics partner for SLE trial recruitment
Clinical Trials Arena
Wed, 10/25/23 - 09:40 am
AbbVie
Lupus Therapeutics
systemic lupus erythematosus
lupus
Rinvoq
clinical trials
Gilead-backed cell therapy startup Kyverna adds fresh funds for new strategy
BioPharma Dive
Thu, 08/3/23 - 10:12 am
Kyverna Therapeutics
lupus
Gilead Sciences
Treg cell therapy
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Mon, 07/24/23 - 10:24 am
Horizon Therapeutics
Amgen
lupus
daxdilimab
clinical trials
GSK underscores organ damage risks for lupus patients in It Will campaign
Medical Marketing and Media
Fri, 07/14/23 - 10:19 am
GSK
DTC ads
lupus
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wed, 05/31/23 - 11:06 am
AbbVie
Rinvoq
Humira
systemic lupus erythematosus
lupus
clinical trials
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Fri, 04/28/23 - 10:46 am
Amgen
earnings
Eli Lilly
lupus
After gathering enough Nektar, Lilly hands back rights to immunology med post-lupus fail
Fierce Biotech
Thu, 04/27/23 - 11:48 am
Eli Lilly
Nektar Therapeutics
Rezpeg
lupus
Fresh layoffs at Nektar Therapeutics as it drops lupus program after phase 2 disappointment
Biopharma Reporter
Thu, 04/20/23 - 10:47 am
Nektar Therapeutics
lupus
rezpegaldesleukin
layoffs
Rezpeg
New lupus partnership with FDA aims to end drug trials’ history of failure
Stat
Thu, 03/30/23 - 11:08 pm
lupus
FDA
clinical trials
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink
Fierce Biotech
Fri, 02/24/23 - 09:27 am
Nektar Therapeutics
rezpegaldesleukin
clinical trials
lupus
Gilead, EVOQ Unite on 'Potential Breakthrough' Treatment for RA, Lupus
BioSpace
Tue, 01/3/23 - 10:28 pm
Gilead Sciences
Evoq Therapeutics
lupus
rheumatoid arthritis
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
Tue, 11/29/22 - 08:29 pm
GSK
lupus
Benlysta
patients
COVID-19
pharma marketing
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Fri, 09/9/22 - 11:07 am
Biogen
litifilimab
lupus
systemic lupus erythematosus
monoclonal antibodies
clinical trials
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
BioSpace
Wed, 08/31/22 - 10:25 am
Aria Pharmaceuticals
patents
lupus
idiopathic pulmonary fibrosis
IPH
chronic kidney disease
Bristol Myers Squibb, with new positive lupus data in hand, readies TYK2 inhibitor for final test
Fierce Biotech
Wed, 06/1/22 - 09:48 am
Bristol Myers Squibb
lupus
psoriasis
deucravacitinib
Pages
1
2
3
4
5
6
7
8
next ›
last »